Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Hemispherx Biopharma Receives New Patent In Europe For Oral Dosed Broad-Spectrum Immune Activators
Hemispherx Biopharma Europe S.A. Completes Agreement With Laboratorios Del Dr. Esteve S.A.
AUDIO WEB REPLAY OF HEMISPHERX'S MAY 16, 2002 CONFERENCE CALL AVAILABLE ON COMPANY'S WEBSITE
HEMISPHERX TO HOST CONFERENCE CALL ON FIRST QUARTER RESULTS AND NEW HIV/AIDS ACTIVITY
HEMISPHERX ANNOUNCES FIRST QUARTER RESULTS REVENUE INCREASED-NET LOSS REDUCED BY 40%
PRESIDENT/OWNER OF MAJOR INTERNATIONAL OIL EXPLORATION COMPANIES JOINS HEMISPHERX BIOPHARMA BOARD OF DIRECTORS
Hemispherx Announces Formation of Committee to Initiate Search For Medical Director to Lead its HIV/AIDS Division
Hemispherx and The AIDS Community Research Initiative of America -- ACRIA -- Launch Immunotherapeutic HIV/AIDS Clinical Trials in New York City
Hemispherx Announces Fourth Quarter and Full Year Results
Hemispherx to Present Today At 1:30 PM On the American Stock Exchange Invitation On Line Conference
76
77
78
79
80
81
82
83
<<
<
>
>>
Privacy